Abstract
Plain Language SummaryThis study examined the clinical features and outcomes of younger patients with idiopathic pulmonary fibrosis (IPF). Results showed that young patients with IPF exhibit lower risks of mortality and lung transplantation but are more often treated with steroids and less frequently with pirfenidone, potentially increasing these risks. These findings highlight the need for a strategic shift toward treatment approaches tailored for younger patients to avoid harmful treatments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
